American Oriental Bioengineering (AOB) Tops Q2 EPS by 1c, Guides In-line for FY Revenues
More News related to AOB
- China Aoxing Pharmaceutical Company to Present at Brean Murray, Carret & Co. 2009 China Growth Conference
- American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009
- China Aoxing Pharmaceutical Company to Present at 2009 China Growth Conference of Adam Friedman Associates on October 28, 2009
- China Aoxing Pharmaceutical Company Reports Fiscal Year 2009 Financial Results
- American Oriental (AOB) Files S-3 to Sell Up to 150M in Shelf Sale
More News related to Earnings
- Ocean Bio-Chem (OBCI) Posts Q3 EPS of $0.07, Lower Y/Y by 1c; Revs Higher
- Highlights From CLWR's Q3 Conference Call: Funding Initiative A Go!, But Investors Worry About Long-Term Outlook
- Arden Group (ARDNA) Posts Q3 EPS of $1.48, Beats Q308 by 18c
- Macy's (M) Shows Good Progress, But Not Good Enough
- Universal Security (UUU) Share Trade Higher on Q2 Earnings Report
American Oriental Bioengineering (NYSE: AOB) reports Q2 EPS of $0.18, 1 cent better than the analyst estimate of $0.17. Revenues for the quarter were $59 million, versus the consensus of $52.83 million.
(Net income for the second quarter of 2008 includes the impact of $0.6 million in loss from unconsolidated entities, related to the Company's minority ownership in China Aoxing)
AOB sees total revenue of at least $245.0 million in the full year 2008 vs. $246.03 million consensus.
American Oriental Bioengineering, Inc., together with its subsidiaries, engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.06Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
AOB
Richard on Aug 11, 2008 10:27 PMThis stock is going to explode!!! It will hit 15-20 a share fast!!!